Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Department of Anesthesia and Intensive Care, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
Severance Hospital, Seoul, Korea, Republic of
University Health Network, Toronto, Ontario, Canada
Emory University Hospital, Atlanta, Georgia, United States
Prof Barjesh Chander Sharma, New Delhi, Delhi, India
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
University Clinical Center of Kosovo, Pristina, Kosovo, Serbia
University of California San Francisco, San Francisco, California, United States
Dept. of Anesthesiology, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.